CTx001 for Geographic Atrophy: A Gene Therapy Expressing Soluble, Truncated Complement Receptor 1 (Mini-CR1)
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Stamatia Zafeiri
- Rachel Green (ORCID: https://orcid.org/0000-0001-9337-2003)
- Sofiya Pisarenka (ORCID: https://orcid.org/0000-0001-5929-4048)
- Peter Emery-Billcliff (ORCID: https://orcid.org/0000-0002-0846-661X)
- Mustafa M. Munye (ORCID: https://orcid.org/0000-0002-2129-1906)
- Viranga Tilakaratna (ORCID: https://orcid.org/0000-0003-4904-498X)
- Athanasios Didangelos (ORCID: https://orcid.org/0000-0002-8835-0974)
- Sonika Rathi (ORCID: https://orcid.org/0000-0003-0484-9952)
- Rafiq Hasan
Institutions
- University of Manchester (GB)
- Charles River Laboratories (United Kingdom) (GB)
- Klinik und Poliklinik für Augenheilkunde Universitätsklinikum Regensburg (DE)
- Universitätsmedizin Rostock (DE)
- STZ eyetrial (DE)
- Genomics (United Kingdom) (GB)
- University of Tübingen (DE)
Publication Details
- Journal
- Ophthalmology Science
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1016/j.xops.2025.100980
- Citations
- 1
- Primary Topic
- Retinal Development and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.81